Dana-Farber's quarterly revenue climbs to $487M: 4 things to know

Boston-based Dana-Farber Cancer Institute's revenue climbed 11.5 percent year over year to $487.2 million in the first quarter of fiscal year 2019, according to financial documents released March 13.

Four things to know:

1. Hospital management said the increase in revenue was largely attributable to growth in patient volume and higher pharmacy revenue.

2. During the first three months of fiscal 2019, Dana-Farber's operating expenses climbed to $454.4 million, an increase of 12.7 percent over the same period of fiscal 2018.

3. Dana-Farber ended the first quarter of fiscal 2019 with operating income of $32.8 million, compared to operating income of $33.8 million in the first quarter of fiscal 2018.

4. After factoring in a $31.6 million investment loss, Dana-Farber recorded a net loss of $1.2 million in the first three months of fiscal 2019. That's compared to the first quarter of fiscal 2018, when the hospital recorded net income of $46.1 million.

More articles on healthcare finance:

Quorum aims to shed up to 9 hospitals
North Carolina agrees to increase reimbursement rates for rural hospitals
14 recent hospital, health system outlook and credit rating actions

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months